$0.1940
-0.008-3.96%
Last update: Nov 3, 5:06 PM
Context Therapeutics Inc (CNTX) Stock Price, Quote, News & History
CNTXNASDAQ
SiTime Corp (SITM) stock rose 30.7% in pre-market trading after beating earnings and sales estimates. Other gainers include CLRO, WYHG, SURG, PAVS, MGRX, CELZ,...
You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.
Other companies in Context Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Context Therapeutics has a consensus price target of $5.69.
The stock price for Context Therapeutics (NASDAQ: CNTX) is $0.2095 last updated November 3, 2026 at 5:06 PM EST.
There are no upcoming dividends for Context Therapeutics.
Context Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Context Therapeutics.
Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer,...
